|
|
||||||||
The Johns Hopkins Medical Institutions, Baltimore, Maryland
Correspondence: For reprints contact: Patricia A. McIntyre, 615 N. Wolfe St., Baltimore, Md. 21205.
ABSTRACT
Indium-111-transferrin (TF) has been described as a hematopoietic marrow scanning agent. The purpose of this study was to compare the metabolism of In·TF and Fe·TF by the erythropoietic marrow. There were marked differences observed between the biologic behavior of these two metals bound to transferrin in all parameters studied. These include: (A) slower plasma clearance of In·TF; (B) significantly greater percentage of 59Fe incorporation in the circulating red cells with only minimal labeling of peripheral red cells with indium and rapid disappearance of the indium-labeled cells from the circulation; (C) significantly greater accumulation of 59Fe in the skeleton; (D) irradiated rabbits' legs showed the expected bone and bone marrow decrease in the uptake of 59Fe-transferrin at 48 hr following 500 rads to the right tibia-fibula unit but no change in 111In·TF or 99mTc-sulfur colloid uptake; (E) in the control nonirradiated legs, 60% of the 59Fe but only 20% of 111In was in the extracted marrow, indicating that the bone concentration of indium was greater than that of 59Fe (p < 0.001); (F) a more rapid uptake of 59Fe·TF by reticulocyterich blood which at 60 min was nine times that of In·TF. These results suggest that the metabolism of indium is significantly different from that of iron with respect to erythropoiesis. The use of 111In·TF as a bone marrow scanning agent must be approached with caution in view of the high indium-to-iron ratio in normal bone and the unchanged accumulation of indium by bone marrow in which the erythroid marrow has been damaged by irradiation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |